Tech

The Download: faking blood and the future of batteries

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/10/2026, 12:35:24 UTC.

Briefings

The article reports on a DARPA $73 million project to develop shelf-stable blood products for military use, aiming for deployment by 2029. It also highlights WeLion New Energy's work on semi-solid-state batteries and discusses drugmakers' claims that GLP-1 weight-loss drugs may slow biological aging. The text notes that while some findings are presented as facts, others remain speculative or unverified.

Key points

• A DARPA initiative funded $73 million to develop dried blood products for battlefield deployment, with a target deployment date of 2029.
• WeLion New Energy is developing semi-solid-state batteries to improve energy density and safety for electric vehicles and drones.

Context and limitations

The article is a newsletter from October 2026, with some claims about drug effects on aging presented as findings but not yet fully validated by independent studies.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 14/10/2026, 13:21:42 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigazbqsghtc3ch6rrhelyrjjxd4t6hnltax4ozuw2aibmubg3g53a